Dr. Woodhead is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1501 N Campbell Ave
Tucson, AZ 85724Phone+1 520-626-7402
Education & Training
University of Arizona College of Medicine-TucsonResidency, Radiology-Diagnostic, 2011 - 2015
Northwestern University The Feinberg School of MedicineClass of 2010
Certifications & Licensure
AZ State Medical License 2016 - 2026
IN State Medical License 2016 - 2023
IL State Medical License 2010 - 2011- American Board of Radiology Interventional Radiology and Diagnostic Radiology
Clinical Trials
- Real-Time Optical Biopsy in Improving Lung Cancer Diagnosis in Patients Undergoing Lung Biopsy Start of enrollment: 2017 Jul 26
Publications & Presentations
PubMed
- 5 citationsClinical and Dosimetric Implications of Calculating Lung Shunt Fraction for Hepatic Yttrium-90 Radioembolization Using SPECT/CT Versus Planar Scintigraphy.Lucas Struycken, Mikin V. Patel, Phillip H. Kuo, Charles Hennemeyer, Gregory Woodhead
AJR. American Journal of Roentgenology. 2021-10-27 - 1 citationsSafety and Feasibility of a Novel Percutaneous Locoregional Injection Technique of Renal Cellular Therapy for Chronic Kidney Disease of Diabetes.Hyeon Yu, Paul D. Sonntag, Peter R. Bream, Michael Lazarowicz, Francis S. Nowakowski
Kidney International Reports. 2021-06-19 - Using FDA-approved drugs as off-label fluorescent dyes for optical biopsies: from in silico design to ex vivo proof-of-conceptMichael C. Larson, Arthur F. Gmitro, Urs Utzinger, Andrew R. Rouse, Gregory Woodhead
Methods and Applications in Fluorescence. 2021-06-04
Press Mentions
Idera Pharmaceuticals Presents Clinical Data from the ILLUMINATE-204 Trial of the Combination of Tilsotolimod and Ipilimumab for Anti-PD-1 Refractory Metastatic Melanoma at the 2018 American Society of Clinical Oncology (ASCO) Annual MeetingJune 4th, 2018
Grant Support
- B-Catenin/Tcf Signaling In Neural Cell Production &FateNational Institute Of Neurological Disorders And Stroke2005–2008
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
